2012’s most popular posts #10 – Almost Alcoholic

This article demonstrates a big problem in understanding addiction and the a big problem in the current diagnostic categories. ...when we think about alcohol abuse or alcoholism, our thoughts often go to situations like this where someone is at a stage where they are doing immediate damage to themselves or others, but what about the stage … Continue reading 2012’s most popular posts #10 – Almost Alcoholic

Anonymity Hurts More Than It Helps???

This video came to my attention through this op-ed. I like the video and agree that making recovery more visible is important in reducing stigma. Last year I wrote: Am I the only one who is really underwhelmed with these recent pieces on whether anonymity in AA has been rendered quaint? To me, they seem to fundamentally misunderstand AA’s anonymity. There’s … Continue reading Anonymity Hurts More Than It Helps???

Intellectual conflicts of interest

Allen Frances, Chair of the DSM-IV Task Force lets loose on the DSM-5. He acknowledges the noxious effects of professional interests on research and practice in a way that is rarely seen from leaders of his stature. [emphasis mine] This is the saddest moment in my 45 year career of studying, practicing, and teaching psychiatry. The Board of … Continue reading Intellectual conflicts of interest

Lines are being drawn

  A major treatment provider, Caron, weighs in on Hazelden's adoption of buprenorphine maintenance treatment:   We use buprenorphine (Suboxone) to assist with the detoxification process from opioids and the length of time can vary depending on the patient’s progress and additional medical issues, such as chronic pain. However, unlike Hazelden’s goal as stated in … Continue reading Lines are being drawn

Response to Why Addiction is NOT a Brain Disease

In a thoughtful post, Marc Lewis questions the disease model of addiction. He doesn't dismiss it out of hand. He seems to look for ways in which it's right and useful. It’s accurate in some ways. It accounts for the neurobiology of addiction better than the “choice” model and other contenders. It explains the helplessness … Continue reading Response to Why Addiction is NOT a Brain Disease

Suboxone Strategy: Protecting Patients Or Profits?

I'm a little late on posting this one, but it still seems worth sharing. Reckitt Benckiser has decided to pull Suboxone tablets from the market. Why? It's an evidence-based decision and an expression of their desire to be a good corporate citizen and their concern for children. Late last month, Reckitt Benckiser created a stir … Continue reading Suboxone Strategy: Protecting Patients Or Profits?